SRT2104: Clinical Trials

9 trials of SRT2104, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 withdrawn. 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 19Completed 8, Withdrawn 1

Follow SRT2104: new trials by email Literature Review of SRT2104 trials Research Report on SRT2104

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
SRT2104 - Colitis, Ulcerative
Phase 1CompletedSirtris, a GSK Company172012-02-132017-06-01
A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers
Placebo, SRT2104 - Healthy Volunteer, Atrophy, Muscular
Phase 1WithdrawnGlaxoSmithKline2011-01-012015-04-17
A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus
Placebo, SRT2104 - Diabetes Mellitus, Type 2
Phase 1CompletedSirtris, a GSK Company382010-05-282017-06-20
Effect of SRT2104 on Endotoxin-induced Inflammation
Placebo, SRT2104 - Sepsis
Phase 1CompletedGlaxoSmithKline412009-12-092017-06-22
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
Placebo, SRT2104 - Atrophy, Muscular
Phase 1CompletedGlaxoSmithKline242009-10-012017-06-16
Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy Volunteers
Placebo, 0.25g SRT2104, Prednisolone - Pulmonary Disease, Chronic Obstructive
Phase 1CompletedGlaxoSmithKline202009-04-062017-07-07
Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male Volunteers
SRT2104, Placebo - Diabetes Mellitus, Type 2
Phase 1CompletedGlaxoSmithKline102009-03-232017-07-07
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers
0.5g SRT2104 - Diabetes Mellitus, Type 2
Phase 1CompletedSirtris, a GSK Company202009-01-202017-07-21
A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers
SRT2104, Placebo - Diabetes Mellitus, Type 2, Healthy Volunteer
Phase 1CompletedSirtris, a GSK Company432008-05-012017-05-30

Conditions studied

Diabetes Mellitus, Type 2 (4)  ·  Muscular Atrophy (2)  ·  Colitis, Ulcerative (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Sepsis (1)

Sponsors

GlaxoSmithKline (5)  ·  Sirtris, a GSK Company (4)

Countries

United Kingdom (6)  ·  Netherlands (1)  ·  United States (1)

Results publications

PMID 23770971, PMID 25978169, PMID 26595549, PMID 27239324, PMID 28912956